Skip to main content

Research Repository

Advanced Search

Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria

Ottonello, Alessandra; Wyllie, Jessica A.; Yahiaoui, Oussama; Sun, Shoujun; Koelln, Rebecca A.; Homer, Joshua A.; Johnson, Robert M.; Murray, Ewan; Williams, Paul; Bolla, Jani R.; Robinson, Carol V.; Fallon, Thomas; Soares da Costa, Tatiana P.; Moses, John E.

Authors

Alessandra Ottonello

Jessica A. Wyllie

Oussama Yahiaoui

Shoujun Sun

Rebecca A. Koelln

Joshua A. Homer

Robert M. Johnson

Ewan Murray

Jani R. Bolla

Carol V. Robinson

Thomas Fallon

Tatiana P. Soares da Costa

John E. Moses



Abstract

The alarming rise in superbugs that are resistant to drugs of last resort, including vancomycin-resistant enterococci and staphylococci, has become a significant global health hazard. Here, we report the click chemistry synthesis of an unprecedented class of shapeshifting vancomycin dimers (SVDs) that display potent activity against bacteria that are resistant to the parent drug, including the ESKAPE pathogens, vancomycin-resistant Enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), as well as vancomycin-resistant S. aureus (VRSA). The shapeshifting modality of the dimers is powered by a triazole-linked bullvalene core, exploiting the dynamic covalent rearrangements of the fluxional carbon cage and creating ligands with the capacity to inhibit bacterial cell wall biosynthesis. The new shapeshifting antibiotics are not disadvantaged by the common mechanism of vancomycin resistance resulting from the alteration of the C-terminal dipeptide with the corresponding d-Ala-d-Lac depsipeptide. Further, evidence suggests that the shapeshifting ligands destabilize the complex formed between the flippase MurJ and lipid II, implying the potential for a new mode of action for polyvalent glycopeptides. The SVDs show little propensity for acquired resistance by enterococci, suggesting that this new class of shapeshifting antibiotic will display durable antimicrobial activity not prone to rapidly acquired clinical resistance.

Citation

Ottonello, A., Wyllie, J. A., Yahiaoui, O., Sun, S., Koelln, R. A., Homer, J. A., Johnson, R. M., Murray, E., Williams, P., Bolla, J. R., Robinson, C. V., Fallon, T., Soares da Costa, T. P., & Moses, J. E. (2023). Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria. Proceedings of the National Academy of Sciences, 120(15), Article e2208737120. https://doi.org/10.1073/pnas.2208737120

Journal Article Type Article
Acceptance Date Feb 24, 2023
Online Publication Date Apr 3, 2023
Publication Date Apr 11, 2023
Deposit Date Apr 12, 2023
Publicly Available Date May 25, 2023
Journal Proceedings of the National Academy of Sciences
Print ISSN 0027-8424
Electronic ISSN 1091-6490
Publisher National Academy of Sciences
Peer Reviewed Peer Reviewed
Volume 120
Issue 15
Article Number e2208737120
DOI https://doi.org/10.1073/pnas.2208737120
Keywords Multidisciplinary
Public URL https://nottingham-repository.worktribe.com/output/19298173
Publisher URL https://www.pnas.org/doi/10.1073/pnas.2208737120

Files





You might also like



Downloadable Citations